Use of bovine-derived collagen matrix in the surgical treatment of empty nose syndrome

Brian H Cameron; Jason Talmadge; Martin J Citardi

doi:10.1002/alr.23449

Use of bovine-derived collagen matrix in the surgical treatment of empty nose syndrome

Int Forum Allergy Rhinol. 2025 Feb;15(2):185-187. doi: 10.1002/alr.23449. Epub 2024 Sep 3.

Authors

Brian H Cameron¹, Jason Talmadge², Martin J Citardi¹

Affiliations

¹ Department of Otorhinolaryngology-Head and Neck Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
² ENT Specialists, PC, Omaha, Nebraska, USA.

PMID: 39225588
DOI: 10.1002/alr.23449

Abstract

Bovine-derived collagen matrix (BDCM) is a safe augmentation material in patients with empty nose syndrome. BDCM augmentation results in clinically and statistically significant improvement in nasal symptoms. Improvements in nasal symptoms with BDCM augmentation may be durable and can be seen up to 2 years postoperative.

Keywords: ENS6Q; augmentation turbinplasty; empty nose syndrome; postoperative.

MeSH terms

Adult
Animals
Cattle
Collagen* / therapeutic use
Female
Humans
Male
Middle Aged
Nose / surgery
Nose Diseases* / surgery
Rhinoplasty* / methods
Syndrome
Treatment Outcome

Substances

Collagen